| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |